1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Disease Models, Animal in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 19 (86.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahrens, BJ; Bading, JR; Chea, J; Ciminera, AK; Colcher, DM; Li, L; Miller, MM; Poku, E; Shively, JE; Weist, MR | 1 |
| Amirdhanayagam, J; Das, T; Dash, A; Guleria, M; Sarma, HD | 1 |
| Hasegawa, K; Hirase, T; Nakamura, I; Node, K; Wada, Y; Watanabe, Y | 1 |
| Balkin, ER; Jia, F; Lewis, MR; Liu, D; Miller, WH; Ruthengael, VC; Shaffer, SM | 1 |
| Andresen, TL; Binderup, T; Jensen, AI; Kjær, A; Kumar EK, P; Rasmussen, PH | 1 |
| Adachi, H; Arakawa, M; Cesati, RR; Connolly, AJ; Dake, BA; Dalal, AR; Emrich, F; Fischbein, MP; Kotek, G; McConnell, MV; Milanesi, M; Okamura, H; Onthank, DC; Pisani, LJ; Robinson, SP; Smit, H | 1 |
| Ackermann, U; Alt, K; Ardipradja, K; Buncic, G; Donnelly, PS; Hagemeyer, CE; Jakoby, B; Lim, B; O'Keefe, GJ; Paterson, BM; Peter, K; Poniger, SS; Schieber, C; Scott, AM; Tochon-Danguy, HJ; Wang, X | 1 |
| Barnhart, TE; Cai, W; Chakravarty, R; Hernandez, R; Hong, H; Valdovinos, HF; Yang, Y | 1 |
| Hayashi, Y; Iguchi, Y; Kitamatsu, M; Matsui, H; Michiue, H; Nishiki, T; Takenaka, F | 1 |
| Arleth, L; Binderup, T; Elema, DR; Huda, P; Jensen, M; Kjær, A; Midtgaard, SR; Pedersen, MC | 1 |
| Bluemke, DA; Davies-Venn, C; Kim, H; Kim, I; Kim, JS; Lee, SJ; Paik, CH; Yang, BY; Yao, Z | 1 |
| Autio, A; Jaakkola, K; Jalkanen, S; Käkelä, M; Lankinen, P; Liljenbäck, H; Mäkilä, J; Roivainen, A; Saanijoki, T; Savisto, N; Siitonen, R; Teuho, J; Virtanen, H | 1 |
| Arano, Y; Fujibayashi, Y; Fukumura, T; Hino, O; Koizumi, M; Saga, T; Sogawa, C; Sudo, H; Sugyo, A; Tsuji, AB; Uehara, T; Yoshida, C; Yoshii, Y | 1 |
| Cai, H; Conti, PS; Huang, CW; Li, Z; Park, R; Shahinian, AH; Wang, H | 1 |
| Bergman, M; Huttunen, M; Luoto, P; Peräkylä, H; Roivainen, A; Simpura, I; Ujula, T; Wilson, I | 1 |
| Azhdarinia, A; Chan, W; Hall, MA; Kwon, S; Lachance, PA; Price, RE; Ranganathan, R; Robinson, H; Sevick-Muraca, EM | 1 |
| Blechert, B; Bruchertseifer, F; Essler, M; Gärtner, FC; Morgenstern, A; Neff, F; Seidl, C; Senekowitsch-Schmidtke, R | 1 |
| Eriksson, SE; Nilsson, R; Ohlsson, T; Tennvall, J | 1 |
| Baek, HS; Choi, SJ; Choi, SM; Hong, YD; Kim, JJ; Lim, JC | 1 |
| Mårtensson, L; Nilsson, R; Ohlsson, T; Senter, P; Sjögren, HO; Strand, SE; Tennvall, J; Wang, Z | 1 |
| Chen, J; de Jong, M; Ginj, M; Maecke, HR; Reubi, JC; Schmitt, JS; Schulz, S; Waser, B | 1 |
| Miao, Y; Quinn, TP; Shelton, T | 1 |
22 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Disease Models, Animal
| Article | Year |
|---|---|
Diagnostic PET Imaging of Mammary Microcalcifications Using
Topics: Alendronate; Animals; Calcinosis; Cell Line, Tumor; Copper Radioisotopes; Disease Models, Animal; Female; Heterocyclic Compounds, 1-Ring; Mammary Neoplasms, Experimental; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2017 |
Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of
Topics: Animals; Cell Line, Tumor; Chelating Agents; Disease Models, Animal; Fibrosarcoma; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Mice; Porphyrins; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2018 |
Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice.
Topics: Animals; Antibodies, Monoclonal; Aorta; Autoradiography; Biomarkers; Cholesterol, Dietary; Copper Radioisotopes; Disease Models, Animal; Early Diagnosis; Heterocyclic Compounds, 1-Ring; Mice; Mice, Knockout; Multimodal Imaging; P-Selectin; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, LDL; Tomography, X-Ray Computed | 2013 |
Comparative biodistributions and dosimetry of [¹⁷⁷Lu]DOTA-anti-bcl-2-PNA-Tyr³-octreotate and [¹⁷⁷Lu]DOTA-Tyr³-octreotate in a mouse model of B-cell lymphoma/leukemia.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Female; Genes, bcl-2; Heterocyclic Compounds, 1-Ring; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lutetium; Lymphoma, B-Cell; Mice; Oligoribonucleotides, Antisense; Peptide Nucleic Acids; Peptides, Cyclic; Proto-Oncogene Mas; Radioisotopes; Radiometry; Tissue Distribution | 2014 |
Positron emission tomography based analysis of long-circulating cross-linked triblock polymeric micelles in a U87MG mouse xenograft model and comparison of DOTA and CB-TE2A as chelators of copper-64.
Topics: Animals; Chelating Agents; Coordination Complexes; Copper Radioisotopes; Disease Models, Animal; Drug Carriers; Female; Glioblastoma; Heterocyclic Compounds, 1-Ring; Mice; Mice, Nude; Micelles; Nanoparticles; Neoplasms, Experimental; Organometallic Compounds; Polymers; Positron-Emission Tomography; Ultraviolet Rays | 2014 |
Assessment of elastin deficit in a Marfan mouse aneurysm model using an elastin-specific magnetic resonance imaging contrast agent.
Topics: Animals; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Chelating Agents; Contrast Media; Disease Models, Animal; Elastin; Feasibility Studies; Heterocyclic Compounds, 1-Ring; Magnetic Resonance Imaging; Male; Marfan Syndrome; Mice; Mice, Inbred C57BL; Reproducibility of Results | 2014 |
Single-chain antibody conjugated to a cage amine chelator and labeled with positron-emitting copper-64 for diagnostic imaging of activated platelets.
Topics: Animals; Blood Platelets; Carotid Arteries; Chelating Agents; Copper; Copper Radioisotopes; Diagnostic Imaging; Disease Models, Animal; Flow Cytometry; Heterocyclic Compounds, 1-Ring; Inflammation; Ligands; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Platelet Activation; Positron-Emission Tomography; Radiopharmaceuticals; Single-Chain Antibodies; Thrombosis; X-Ray Microtomography | 2014 |
(44)Sc: an attractive isotope for peptide-based PET imaging.
Topics: Amino Acid Motifs; Animals; Binding, Competitive; Calcium; Cell Line, Tumor; Disease Models, Animal; Heterocyclic Compounds, 1-Ring; Humans; Image Processing, Computer-Assisted; Inhibitory Concentration 50; Integrin alphaVbeta3; Mice; Molecular Imaging; Neoplasm Transplantation; Neoplasms; Oligopeptides; Peptides; Positron-Emission Tomography; Radioisotopes; Scandium; Tissue Distribution | 2014 |
Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model.
Topics: Animals; Arginine; Boron; Boron Neutron Capture Therapy; Boronic Acids; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Copper; Disease Models, Animal; Drug Delivery Systems; Female; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Peptides; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
PET/CT Based In Vivo Evaluation of 64Cu Labelled Nanodiscs in Tumor Bearing Mice.
Topics: Animals; Cell Line, Tumor; Copper Radioisotopes; Disease Models, Animal; Heterocyclic Compounds, 1-Ring; Heterografts; Humans; Mice; Nanostructures; Neoplasms; Particle Size; Phosphatidylcholines; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
64Cu-DOTA as a surrogate positron analog of Gd-DOTA for cardiac fibrosis detection with PET: pharmacokinetic study in a rat model of chronic MI.
Topics: Animals; Autoradiography; Chronic Disease; Copper Radioisotopes; Disease Models, Animal; Drug Stability; Electrons; Fibrosis; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Myocardial Infarction; Myocardium; Organometallic Compounds; Positron-Emission Tomography; Rats | 2016 |
68Ga-DOTA-Siglec-9--a new imaging tool to detect synovitis.
Topics: Amine Oxidase (Copper-Containing); Animals; Antigens, CD; Arthritis, Rheumatoid; Cell Adhesion Molecules; Chromatography, High Pressure Liquid; Disease Models, Animal; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Immunohistochemistry; Male; Positron-Emission Tomography; Protein Stability; Rabbits; Radiopharmaceuticals; Sialic Acid Binding Immunoglobulin-like Lectins; Synovitis | 2015 |
Development of positron emission tomography imaging by 64Cu-labeled Fab for detecting ERC/mesothelin in a mesothelioma mouse model.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Heterocyclic Compounds, 1-Ring; Humans; Immunoglobulin Fab Fragments; Immunoglobulin G; Indium Radioisotopes; Iodine Radioisotopes; Membrane Glycoproteins; Mesothelin; Mesothelioma; Mice; Mice, Inbred BALB C; Positron-Emission Tomography | 2010 |
Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression.
Topics: Animals; Benzoates; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Chelating Agents; Copper Radioisotopes; Disease Models, Animal; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Mice; Mice, Nude; Molecular Conformation; Neoplasms, Experimental; Peptides, Cyclic; Positron-Emission Tomography; Tissue Distribution | 2010 |
Matrix metalloproteinase 9 targeting peptides: syntheses, 68Ga-labeling, and preliminary evaluation in a rat melanoma xenograft model.
Topics: Animals; Cell Line, Tumor; Cystine; Disease Models, Animal; Drug Evaluation; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Kinetics; Matrix Metalloproteinase 9; Melanoma; Peptides; Positron-Emission Tomography; Rats; Tissue Distribution; Transplantation, Heterologous; Tumor Protein, Translationally-Controlled 1 | 2010 |
Imaging prostate cancer lymph node metastases with a multimodality contrast agent.
Topics: Animals; Antigens, Neoplasm; Cell Adhesion Molecules; Cell Line, Tumor; Contrast Media; Copper Radioisotopes; Disease Models, Animal; Epithelial Cell Adhesion Molecule; Heterocyclic Compounds, 1-Ring; Humans; Indoles; Lymph Nodes; Lymphatic Metastasis; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Reproducibility of Results; ROC Curve; Tomography, X-Ray Computed | 2012 |
Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis.
Topics: Actinium; Animals; Bismuth; Cell Line, Tumor; Disease Models, Animal; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Kidney; Mice; Organometallic Compounds; Pentetic Acid; Peptides; Peritoneal Neoplasms; Radioisotopes; Treatment Outcome; Xenograft Model Antitumor Assays | 2012 |
Treatment with unlabeled mAb BR96 after radioimmunotherapy with 177Lu-DOTA-BR96 in a syngeneic rat colon carcinoma model.
Topics: Animals; Antibodies, Monoclonal; Chelating Agents; Colonic Neoplasms; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Heterocyclic Compounds, 1-Ring; Immunoenzyme Techniques; Lutetium; Male; Radioimmunotherapy; Radioisotopes; Rats; Rats, Inbred BN | 2012 |
Synthesis and biological evaluation of a novel (177)Lu-DOTA-[Gly(3)-cyclized(Dap(4), (d)-Phe(7), Asp(10))-Arg(11)]α-MSH(3-13) analogue for melanocortin-1 receptor-positive tumor targeting.
Topics: alpha-MSH; Animals; Disease Models, Animal; Drug Delivery Systems; Drug Stability; Female; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Lutetium; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligopeptides; Radioisotopes; Radiopharmaceuticals; Receptor, Melanocortin, Type 1; Tissue Distribution | 2012 |
Determining maximal tolerable dose of the monoclonal antibody BR96 labeled with 90Y or 177Lu in rats: establishment of a syngeneic tumor model to evaluate means to improve radioimmunotherapy.
Topics: Animals; Antibodies, Monoclonal; Biotin; Body Weight; Brain; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Heterocyclic Compounds, 1-Ring; Leukocytes; Lutetium; Maximum Tolerated Dose; Platelet Count; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rats; Time Factors; Yttrium Radioisotopes | 2005 |
Design, synthesis, and biological evaluation of somatostatin-based radiopeptides.
Topics: Animals; Cell Line; Disease Models, Animal; Drug Design; Drug Screening Assays, Antitumor; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Male; Molecular Conformation; Neoplasm Transplantation; Octreotide; Pancreatic Neoplasms; Rats; Rats, Inbred Lew; Receptors, Somatostatin; Somatostatin; Stereoisomerism; Time Factors; Tissue Distribution; Tumor Cells, Cultured; Yttrium Radioisotopes | 2006 |
Therapeutic efficacy of a 177Lu-labeled DOTA conjugated alpha-melanocyte-stimulating hormone peptide in a murine melanoma-bearing mouse model.
Topics: alpha-MSH; Animals; Arginine; Chelating Agents; Disease Models, Animal; Heterocyclic Compounds, 1-Ring; Kidney; Lutetium; Melanoma; Mice; Radiography; Radioisotopes; Survival Analysis | 2007 |